These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 12140559)

  • 1. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.
    Moore SA; Saito F; Chen J; Michele DE; Henry MD; Messing A; Cohn RD; Ross-Barta SE; Westra S; Williamson RA; Hoshi T; Campbell KP
    Nature; 2002 Jul; 418(6896):422-5. PubMed ID: 12140559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
    Michele DE; Barresi R; Kanagawa M; Saito F; Cohn RD; Satz JS; Dollar J; Nishino I; Kelley RI; Somer H; Straub V; Mathews KD; Moore SA; Campbell KP
    Nature; 2002 Jul; 418(6896):417-22. PubMed ID: 12140558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
    Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
    Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full circle to cobbled brain.
    Ross ME
    Nature; 2002 Jul; 418(6896):376-7. PubMed ID: 12140540
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dystroglycan linkage and muscular dystrophy].
    Shimizu T
    Rinsho Shinkeigaku; 2002 Nov; 42(11):1091-4. PubMed ID: 12784674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation defects: a new mechanism for muscular dystrophy?
    Grewal PK; Hewitt JE
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R259-64. PubMed ID: 12925572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective glycosylation in muscular dystrophy.
    Muntoni F; Brockington M; Blake DJ; Torelli S; Brown SC
    Lancet; 2002 Nov; 360(9343):1419-21. PubMed ID: 12424008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
    Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein glycosylation in disease: new insights into the congenital muscular dystrophies.
    Martin-Rendon E; Blake DJ
    Trends Pharmacol Sci; 2003 Apr; 24(4):178-83. PubMed ID: 12707004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin.
    Yamamoto T; Kato Y; Kawaguchi M; Shibata N; Kobayashi M
    Med Electron Microsc; 2004 Dec; 37(4):200-7. PubMed ID: 15614444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
    Matsumura K; Campbell KP
    Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fukuyama-type congenital muscular dystrophy (FCMD) and alpha-dystroglycanopathy.
    Toda T; Kobayashi K; Takeda S; Sasaki J; Kurahashi H; Kano H; Tachikawa M; Wang F; Nagai Y; Taniguchi K; Taniguchi M; Sunada Y; Terashima T; Endo T; Matsumura K
    Congenit Anom (Kyoto); 2003 Jun; 43(2):97-104. PubMed ID: 12893968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy].
    Toda T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells.
    Langenbach KJ; Rando TA
    Muscle Nerve; 2002 Nov; 26(5):644-53. PubMed ID: 12402286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered glycosylation of alpha-dystroglycan in neurons of Fukuyama congenital muscular dystrophy brains.
    Saito Y; Yamamoto T; Mizuguchi M; Kobayashi M; Saito K; Ohno K; Osawa M
    Brain Res; 2006 Feb; 1075(1):223-8. PubMed ID: 16466646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.
    Martin PT
    Glycobiology; 2003 Aug; 13(8):55R-66R. PubMed ID: 12736199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fukutin deficiency in the developing mouse brain.
    Chiyonobu T; Sasaki J; Nagai Y; Takeda S; Funakoshi H; Nakamura T; Sugimoto T; Toda T
    Neuromuscul Disord; 2005 Jun; 15(6):416-26. PubMed ID: 15907289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fukutin expression in mouse non-muscle somatic organs: its relationship to the hypoglycosylation of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
    Saito Y; Yamamoto T; Ohtsuka-Tsurumi E; Oka A; Mizuguchi M; Itoh M; Voit T; Kato Y; Kobayashi M; Saito K; Osawa M
    Brain Dev; 2004 Oct; 26(7):469-79. PubMed ID: 15351084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex.
    Sciandra F; Bozzi M; Bianchi M; Pavoni E; Giardina B; Brancaccio A
    Ann Ist Super Sanita; 2003; 39(2):173-81. PubMed ID: 14587215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular recognition by LARGE is essential for expression of functional dystroglycan.
    Kanagawa M; Saito F; Kunz S; Yoshida-Moriguchi T; Barresi R; Kobayashi YM; Muschler J; Dumanski JP; Michele DE; Oldstone MB; Campbell KP
    Cell; 2004 Jun; 117(7):953-64. PubMed ID: 15210115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.